This brief reports what ServiceNow's 10-Q, filed 2025-07-24, states, and nothing else. Every item below is a sentence the filing contains, quoted exactly and verified character-for-character against the document fetched from EDGAR. No inference is drawn and no claim is made about what any figure means.
The figures
| Metric | Value | Period |
|---|---|---|
| RPO | $23.9 billion | June 30, 2025 |
| RPO | 29% | June 30, 2025 |
| CRPO | 24% | June 30, 2025 |
| Income tax provision | $86 million | three months ended June 30, 2025 |
| Income tax provision | $181 million | six months ended June 30, 2025 |
| Income tax provision | $72 million | three months ended June 30, 2024 |
| Income tax provision | $150 million | six months ended June 30, 2024 |
| Effective tax rate | 18% | three months ended June 30, 2025 |
| Effective tax rate | 22% | three months ended June 30, 2024 |
| Effective tax rate | 18% | six months ended June 30, 2025 |
| Effective tax rate | 20% | six months ended June 30, 2024 |
| Renewal rate | 98% | last three years |
| Cash and cash equivalents, short-term investments and long-term investments | $10.8 billion | June 30, 2025 |
| Operating lease obligations | $1,085 million | — |
| Operating lease obligations due over the next five years | $656 million | next five years |
| Shares of common stock repurchased | 0.4 million | three months ended June 30, 2025 |
| Shares of common stock repurchased | 0.7 million | six months ended June 30, 2025 |
| Amount spent on common stock repurchases | $361 million | three months ended June 30, 2025 |
| Amount spent on common stock repurchases | $659 million | six months ended June 30, 2025 |
| Authorized amount under the share repurchase program remaining available | $2.6 billion | June 30, 2025 |
| Net cash provided by operating activities | $2,393 million | six months ended June 30, 2025 |
| Net cash provided by operating activities | $1,961 million | six months ended June 30, 2024 |
| Net cash used in investing activities | $640 million | six months ended June 30, 2025 |
| Net cash used in investing activities | $1,105 million | six months ended June 30, 2024 |
| Cash and cash equivalents, short-term investments and long-term investments | $10.8 billion | June 30, 2025 |
| Operating lease obligations | $1,085 million | — |
| Outstanding payment obligations to suppliers participating in the SCF program | $49 million | June 30, 2025 |
| Share repurchase program | $1.5 billion | May 2023 |
| Share repurchase program | $3.0 billion | January 2025 |
| Company repurchases of common stock | 0.4 million shares | three months ended June 30, 2025 |
| Company repurchases of common stock | 0.7 million shares | six months ended June 30, 2025 |
| Company repurchases of common stock | $361 million | three months ended June 30, 2025 |
| Company repurchases of common stock | $659 million | six months ended June 30, 2025 |
| Authorized amount under the share repurchase program | $2.6 billion | June 30, 2025 |
| Net cash provided by operating activities | $2,393 million | six months ended June 30, 2025 |
| Net cash provided by operating activities | $1,961 million | six months ended June 30, 2024 |
| Net cash used in investing activities | $640 million | six months ended June 30, 2025 |
| Net cash used in investing activities | $1,105 million | six months ended June 30, 2024 |
| Net cash used in financing activities | $944 million | six months ended June 30, 2025 |
| Net cash used in financing activities | $580 million | six months ended June 30, 2024 |
| Sales and marketing expenses | $168 million | three months ended June 30, 2025 |
| Personnel-related costs including stock-based compensation and overhead expenses | $103 million | three months ended June 30, 2025 |
| Personnel-related costs including stock-based compensation and overhead expenses | $203 million | six months ended June 30, 2025 |
| Research and development (“R&D”) expenses | $91 million | three months ended June 30, 2025 |
| Research and development (“R&D”) expenses | $188 million | six months ended June 30, 2025 |
| Personnel-related costs including stock-based compensation and overhead expenses | $85 million | three months ended June 30, 2025 |
| Personnel-related costs including stock-based compensation and overhead expenses | $168 million | six months ended June 30, 2025 |
| General and administrative (“G&A”) expenses | $39 million | three months ended June 30, 2025 |
| General and administrative (“G&A”) expenses | $46 million | six months ended June 30, 2025 |
Every figure above is quoted from the filing; the sentence it was read from appears under its beat below.
The evidence, by beat
ARR / NRR / NDR growth or dilution
As of June 30, 2025, our RPO was $23.9 billion, of which 46% represented cRPO.
RPO and cRPO increased by 29% and 24%, respectively, compared to June 30, 2024.
RPO and cRPO increased by 29% and 24%, respectively, compared to June 30, 2024.
competitive displacement / win-loss / platform consolidation
Our income tax provision was $86 million and $181 million for the three and six months ended June 30, 2025, respectively, and $72 million and $150 million for the three and six months ended June 30, 2024, respectively.
Our income tax provision was $86 million and $181 million for the three and six months ended June 30, 2025, respectively, and $72 million and $150 million for the three and six months ended June 30, 2024, respectively.
Our income tax provision was $86 million and $181 million for the three and six months ended June 30, 2025, respectively, and $72 million and $150 million for the three and six months ended June 30, 2024, respectively.
Our income tax provision was $86 million and $181 million for the three and six months ended June 30, 2025, respectively, and $72 million and $150 million for the three and six months ended June 30, 2024, respectively.
Effective tax rate18%22%18%20%
Effective tax rate18%22%18%20%
Effective tax rate18%22%18%20%
Effective tax rate18%22%18%20%
we have experienced a renewal rate of 98% over the last three years.
cash and cash equivalents, short-term investments and long-term investments totaling $10.8 billion as of June 30, 2025.
Operating lease obligations totaling $1,085 million are principally associated with leased facilities and have varying maturities with $656 million due over the next five years.
Operating lease obligations totaling $1,085 million are principally associated with leased facilities and have varying maturities with $656 million due over the next five years.
During the three and six months ended June 30, 2025, the Company repurchased 0.4 million and 0.7 million shares of our common stock for $361 million and $659 million, respectively.
During the three and six months ended June 30, 2025, the Company repurchased 0.4 million and 0.7 million shares of our common stock for $361 million and $659 million, respectively.
During the three and six months ended June 30, 2025, the Company repurchased 0.4 million and 0.7 million shares of our common stock for $361 million and $659 million, respectively.
During the three and six months ended June 30, 2025, the Company repurchased 0.4 million and 0.7 million shares of our common stock for $361 million and $659 million, respectively.
As of June 30, 2025, approximately $2.6 billion of the authorized amount under the share repurchase program remained available for future repurchases.
Net cash provided by operating activities was $2,393 million for the six months ended June 30, 2025 compared to $1,961 million for the six months ended June 30, 2024.
Net cash provided by operating activities was $2,393 million for the six months ended June 30, 2025 compared to $1,961 million for the six months ended June 30, 2024.
Net cash used in investing activities was $640 million for the six months ended June 30, 2025 compared to $1,105 million for the six months ended June 30, 2024.
Net cash used in investing activities was $640 million for the six months ended June 30, 2025 compared to $1,105 million for the six months ended June 30, 2024.
AI product monetisation / attach
The filing names this beat, but no statement in it verified as a verbatim quote, so none is reported here.
guidance raised/cut, outlook change
we expect to grow our business and generate positive cash flows from operations during 2025.
cash and cash equivalents, short-term investments and long-term investments totaling $10.8 billion as of June 30, 2025.
Operating lease obligations totaling $1,085 million are principally associated with leased facilities and have varying maturities with $656 million due over the next five years.
As of June 30, 2025, our outstanding payment obligations to suppliers participating in the SCF program totaled $49 million.
In May 2023, our board of directors authorized a program to repurchase up to $1.5 billion of our common stock and authorized an additional $3.0 billion in repurchases under the program in January 2025.
In May 2023, our board of directors authorized a program to repurchase up to $1.5 billion of our common stock and authorized an additional $3.0 billion in repurchases under the program in January 2025.
During the three and six months ended June 30, 2025, the Company repurchased 0.4 million and 0.7 million shares of our common stock for $361 million and $659 million, respectively.
During the three and six months ended June 30, 2025, the Company repurchased 0.4 million and 0.7 million shares of our common stock for $361 million and $659 million, respectively.
During the three and six months ended June 30, 2025, the Company repurchased 0.4 million and 0.7 million shares of our common stock for $361 million and $659 million, respectively.
During the three and six months ended June 30, 2025, the Company repurchased 0.4 million and 0.7 million shares of our common stock for $361 million and $659 million, respectively.
As of June 30, 2025, approximately $2.6 billion of the authorized amount under the share repurchase program remained available for future repurchases.
Net cash provided by operating activities was $2,393 million for the six months ended June 30, 2025 compared to $1,961 million for the six months ended June 30, 2024.
Net cash provided by operating activities was $2,393 million for the six months ended June 30, 2025 compared to $1,961 million for the six months ended June 30, 2024.
Net cash used in investing activities was $640 million for the six months ended June 30, 2025 compared to $1,105 million for the six months ended June 30, 2024.
Net cash used in investing activities was $640 million for the six months ended June 30, 2025 compared to $1,105 million for the six months ended June 30, 2024.
Net cash used in financing activities was $944 million for the six months ended June 30, 2025 compared to $580 million for the six months ended June 30, 2024.
Net cash used in financing activities was $944 million for the six months ended June 30, 2025 compared to $580 million for the six months ended June 30, 2024.
We anticipate cash flows generated from operations, cash, cash equivalents and investments will be sufficient to meet our liquidity needs for at least the next 12 months.
cost action / restructuring / headcount
Sales and marketing expenses increased by $168 million and $299 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to increased headcount resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $103 million and $203 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024.
Sales and marketing expenses increased by $168 million and $299 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to increased headcount resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $103 million and $203 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024.
Sales and marketing expenses increased by $168 million and $299 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to increased headcount resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $103 million and $203 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024.
Research and development (“R&D”) expenses increased by $91 million and $188 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to increased headcount, resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $85 million and $168 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024.
Research and development (“R&D”) expenses increased by $91 million and $188 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to increased headcount, resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $85 million and $168 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024.
Research and development (“R&D”) expenses increased by $91 million and $188 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to increased headcount, resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $85 million and $168 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024.
Research and development (“R&D”) expenses increased by $91 million and $188 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to increased headcount, resulting in an increase in personnel-related costs including stock-based compensation and overhead expenses of $85 million and $168 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024.
General and administrative (“G&A”) expenses increased by $39 million and $46 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to impairment of assets of $30 million and an increase in personnel-related costs, including stock-based compensation.
General and administrative (“G&A”) expenses increased by $39 million and $46 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to impairment of assets of $30 million and an increase in personnel-related costs, including stock-based compensation.
General and administrative (“G&A”) expenses increased by $39 million and $46 million for the three and six months ended June 30, 2025, respectively, compared to the three and six months ended June 30, 2024, primarily due to impairment of assets of $30 million and an increase in personnel-related costs, including stock-based compensation.
Verification ledger
- 60 statements proposed by the extractor
- 52 verified verbatim against the fetched filing (87%)
- 8 discarded — not quotable character-for-character
The verbatim check contains no model: the extractor proposes a statement, and a deterministic substring match against the fetched text decides whether it is admissible. A proposal that does not verify is dropped.
This brief publishes no inference and no synthesis. The publication's inference layer must clear a measured second-lab confirmation threshold before it may appear; it has not, so it is absent by rule rather than by omission.